PP
Paramount Peptides
Tirzepatide
189 tests · latest 02 Mar 2026
66%
NEA rating
#10 of 23 Tirzepatide vendors
2 of 4 classifiable tests passed
natural 88% · customers 3.8★ (30)
NEA analysis · Tirzepatide
Paramount Peptides Tirzepatide is a mixed picture: purity reads 96.9% while fill comes in light at 90.5% of label. Expect batch to batch swings and confirm the lot before relying on the number.
Purity focus — purity 99.5%+, dose ±35%methodology
Peptides
14 rated · tap to focus| # | Peptide | Rating | N |
|---|---|---|---|
| 1 | Tirzepatideselected | 66% | 4 |
| 2 | Cagrilintide | 56% | 10 |
| 3 | Thymosin Alpha 1 | 50% | 20 |
| 4 | BPC 157 | 33% | 17 |
| 5 | GLOW | 29% | 26 |
| 6 | TB 500 | 26% | 3 |
| 7 | AOD 9604 | 6% | 33 |
| 8 | PT 141 | 4% | 3 |
| 9 | Retatrutide | 0% | 16 |
| 10 | Semaglutide | 0% | 11 |
| 11 | Melanotan II | 0% | 1 |
| 12 | Epithalon | 0% | 16 |
| 13 | Hexarelin | 0% | 14 |
| 14 | SS 31 | 0% | 15 |
Rating trend
Tirzepatide rating from this vendor, after each test
Paramount Peptides Tirzepatide test history
4 tests · 2 pass · 2 fail
| Date | Result | Purity | Dosage | Label |
|---|---|---|---|---|
| 2 Mar 2026 | Fail | 97.32%Content Fail | -14.4%8.56 mg tested / 10 mg label | Batch TI202604sent by Public |
| 17 Feb 2026 | Fail | 96.67%Content Fail | -16.5%8.35 mg tested / 10 mg label | Batch TI202603sent by Public |
| 30 Jan 2026 | Pass | 95.8%Identity Pass | -3.8%9.62 mg tested / 10 mg label | Batch TI202602sent by Vendor |
| 17 Jan 2026 | Pass | 97.81%Identity Pass | -3.3%9.67 mg tested / 10 mg label | Batch TI202601sent by Vendor |
1-4 of 4